SEC Comment Letter 0000000000-22-012323 to Edwards Lifesciences Corp (EW) (CIK 0001099800) (EW)

Edwards Lifesciences Corp (EW) (CIK 0001099800)
Date: Nov. 14, 2022 · CIK: 0001099800 · Accession: 0000000000-22-012323

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-15525

Date

November 14, 2022

Author

Not clearly detected

Form

UPLOAD

Company

Edwards Lifesciences Corp (EW) (CIK 0001099800)

Letter

United States securities and exchange commission logo November 14, 2022 Michael A. Mussallem Chief Executive Officer Edwards Lifesciences Corp One Edwards Way Irvine, California 92614 Re:Edwards Lifesciences Corp Definitive Proxy Statement on Schedule 14A Filed March 22, 2022 File No. 001-15525 Dear Michael A. Mussallem: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text

United States securities and exchange commission logo
November 14, 2022
Michael A. Mussallem
Chief Executive Officer
Edwards Lifesciences Corp
One Edwards Way
Irvine, California 92614
Re:Edwards Lifesciences Corp
Definitive Proxy Statement on Schedule 14A
Filed March 22, 2022
File No. 001-15525
Dear Michael A. Mussallem:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program

SecProbe.io